Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）
NCT07069894 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5400
Last updated 2025-07-17
Summary
Xuebijing injection (XBJ) showed proven efficacy in the EXIT-SEP trial (NCT03238742), lowering 28-day mortality. However, its real-world effectiveness requires validation due to the trial's strict criteria. Broader clinical evaluation is imperative.
Conditions
Sponsors & Collaborators
-
Southeast University, China
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2026-10-31
- Completion
- 2027-09-30
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients
NCT03645668 ·Status: COMPLETED ·Phase: PHASE4
-
Sivelestat for Acute Respiratory Distress Syndrome Due to COVID-19
NCT05697016 ·Status: UNKNOWN ·Phase: NA
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock
NCT03948048 ·Status: RECRUITING
-
Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure
NCT00633477 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock Patients
NCT03151668 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract Infection
NCT02871024 ·Status: TERMINATED ·Phase: NA
-
Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
NCT03620409 ·Status: COMPLETED
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
Efficacy of SGLT2 Inhibitors in Adults With Sepsis
NCT06473844 ·Status: RECRUITING ·Phase: NA
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
NCT03237728 ·Status: COMPLETED ·Phase: PHASE1
-
Dexmedetomidine on Microcirculation in Septic Shock
NCT02270281 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
A Study of Exosome Proteomics and Hemodynamics in Sepsis
NCT03267160 ·Status: COMPLETED
-
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
NCT06220929 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection
NCT02842437 ·Status: UNKNOWN ·Phase: NA
-
Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis
NCT04973670 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of R-spondin3 on Sepsis Induced Endothelial Dysfunction
NCT04546919 ·Status: UNKNOWN
-
Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis
NCT02605681 ·Status: COMPLETED
-
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611 ·Status: COMPLETED ·Phase: PHASE3
-
Early Vasopressors in Sepsis
NCT05179499 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment of IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.
NCT04850443 ·Status: WITHDRAWN
-
Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis
NCT06874634 ·Status: COMPLETED
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED